BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 19635049)

  • 1. Towards understanding the free and receptor bound conformation of neuropeptide Y by fluorescence resonance energy transfer studies.
    Haack M; Beck-Sickinger AG
    Chem Biol Drug Des; 2009 Jun; 73(6):573-83. PubMed ID: 19635049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural similarities of micelle-bound peptide YY (PYY) and neuropeptide Y (NPY) are related to their affinity profiles at the Y receptors.
    Lerch M; Mayrhofer M; Zerbe O
    J Mol Biol; 2004 Jun; 339(5):1153-68. PubMed ID: 15178255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strongly altered receptor binding properties in PP and NPY chimeras are accompanied by changes in structure and membrane binding.
    Lerch M; Kamimori H; Folkers G; Aguilar MI; Beck-Sickinger AG; Zerbe O
    Biochemistry; 2005 Jun; 44(25):9255-64. PubMed ID: 15966750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of the structure of the N-terminal domain from the Y4 receptor - a G protein-coupled receptor - and its interaction with hormones from the NPY family.
    Zou C; Kumaran S; Markovic S; Walser R; Zerbe O
    Chembiochem; 2008 Sep; 9(14):2276-84. PubMed ID: 18767100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular recognition of the NPY hormone family by their receptors.
    Lindner D; Stichel J; Beck-Sickinger AG
    Nutrition; 2008 Sep; 24(9):907-17. PubMed ID: 18725086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family.
    Cabrele C; Beck-Sickinger AG
    J Pept Sci; 2000 Mar; 6(3):97-122. PubMed ID: 10759209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning and characterization of rabbit neuropeptide Y receptor subtypes.
    Umeda T; Kanatani A; Iwaasa H
    Peptides; 2009 Aug; 30(8):1441-7. PubMed ID: 19481128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biophysical methods to study ligand-receptor interactions of neuropeptide Y.
    Bettio A; Beck-Sickinger AG
    Biopolymers; 2001; 60(6):420-37. PubMed ID: 12209475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPC receptors and not ligands decide the binding mode in neuropeptide Y multireceptor/multiligand system.
    Lindner D; van Dieck J; Merten N; Mörl K; Günther R; Hofmann HJ; Beck-Sickinger AG
    Biochemistry; 2008 Jun; 47(22):5905-14. PubMed ID: 18457425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence- and luminescence-based methods for the determination of affinity and activity of neuropeptide Y2 receptor ligands.
    Ziemek R; Brennauer A; Schneider E; Cabrele C; Beck-Sickinger AG; Bernhardt G; Buschauer A
    Eur J Pharmacol; 2006 Dec; 551(1-3):10-8. PubMed ID: 17027743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further characterization of neuropeptide Y receptor subtypes using centrally truncated analogs of neuropeptide Y: evidence for subtype-differentiating effects on affinity and intrinsic efficacy.
    Michel MC; Gaida W; Beck-Sickinger AG; Wieland HA; Doods H; Dürr H; Jung G; Schnorrenberg G
    Mol Pharmacol; 1992 Oct; 42(4):642-8. PubMed ID: 1331755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High affinity displacement of [(3)H]NPY binding to the crude venom of conus anemone by insect neuropeptides.
    Le MT; Vanderheyden PM; De Backer JP; Vanquelin G; Broeck JV
    Biochem Biophys Res Commun; 1999 Aug; 262(1):180-6. PubMed ID: 10448089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rational approach for the development of reduced-size analogues of neuropeptide Y with high affinity to the Y1 receptor.
    Rist B; Wieland HA; Willim KD; Beck-Sickinger AG
    J Pept Sci; 1995; 1(5):341-8. PubMed ID: 9223013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of neuropeptide Y analogues with respect to Y1 and Y2 receptors.
    Beck-Sickinger AG; Jung G
    Biopolymers; 1995; 37(2):123-42. PubMed ID: 7893945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chicken neuropeptide Y-family receptor Y4: a receptor with equal affinity for pancreatic polypeptide, neuropeptide Y and peptide YY.
    Lundell I; Boswell T; Larhammar D
    J Mol Endocrinol; 2002 Jun; 28(3):225-35. PubMed ID: 12063188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FMRFamides exert a unique modulation of rodent pancreatic polypeptide sensitive neuropeptide Y (NPY) receptors.
    Parker SL; Parker MS
    Can J Physiol Pharmacol; 2000 Feb; 78(2):150-61. PubMed ID: 10737678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y receptors: ligand binding and trafficking suggest novel approaches in drug development.
    Walther C; Mörl K; Beck-Sickinger AG
    J Pept Sci; 2011 Apr; 17(4):233-46. PubMed ID: 21351324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide Y receptors; antisecretory control of intestinal epithelial function.
    Cox HM
    Auton Neurosci; 2007 Apr; 133(1):76-85. PubMed ID: 17140858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide Y as a partial agonist of the Y1 receptor.
    Sah R; Balasubramaniam A; Parker MS; Sallee F; Parker SL
    Eur J Pharmacol; 2005 Nov; 525(1-3):60-8. PubMed ID: 16293244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional role of the extracellular N-terminal domain of neuropeptide Y subfamily receptors in membrane integration and agonist-stimulated internalization.
    Lindner D; Walther C; Tennemann A; Beck-Sickinger AG
    Cell Signal; 2009 Jan; 21(1):61-8. PubMed ID: 18845246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.